Substance / Medication

Tinzaparin sodium

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

30 trials linked to this intervention

30
Total Trials
9
Recruiting
5
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Safety and effectiveness of tinzaparin sodium in the management of recurrent pregnancy loss.
Dendrinos S, Kalogirou I, Makrakis E et al. · Clin Exp Obstet Gynecol · 2007
PMID: 17937086RCT
Comparison of the antiangiogenic effects of heparin sodium, enoxaparin sodium, and tinzaparin sodium by using chorioallantoic membrane assay.
Katrancioglu Nurkay, Karahan Oguz, Kilic Ahmet Turhan et al. · Blood Coagul Fibrinolysis · 2012
PMID: 22343683Observational
Antiangiogenic activities of bemiparin sodium, enoxaparin sodium, nadroparin calcium and tinzaparin sodium.
Dogan Omer Tamer, Polat Zubeyde Akin, Karahan Oguz et al. · Thromb Res · 2011
PMID: 21605890Observational
Profile of low molecular weight tinzaparin sodium for anticoagulation during hemodialysis.
Al-Saran Khalid A, Sabry Alaa, Taha Moammer et al. · Saudi J Kidney Dis Transpl · 2010
PMID: 20061691Observational
Cost effectiveness of tinzaparin sodium versus unfractionated heparin in the treatment of proximal deep vein thrombosis.
Caro J Jaime, Getsios Denis, Caro Ingrid et al. · Pharmacoeconomics · 2002
PMID: 12141887Observational
Nail discoloration due to tinzaparin sodium.
Takci Zennure, Ozoguz Pinar · Cutan Ocul Toxicol · 2012
PMID: 22257152Case Report
Tinzaparin Sodium Pharmacokinetics in Patients with Chronic Kidney Disease: Practical Implications.
Helfer Hélène, Siguret Virginie, Mahé Isabelle · Am J Cardiovasc Drugs · 2020
PMID: 31721053ReviewFull text (PMC)
The effect of tinzaparin sodium and leuprolide acetate in an experimental mouse model of endometriosis: The rol of the WNT/beta-catenin pathway.
Albak Yasemin, Sönmez Ünal Gamze, Yıldız Çağlar et al. · Turk J Obstet Gynecol · 2026
PMID: 41608884Other

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Tinzaparin sodium (substance)
SNOMED CT
395908006
UMLS CUI
C0354599

Clinical Data

This intervention maps to 3 entities in the Healos knowledge graph.

3
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
30
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.

Tinzaparin sodium — Conditions, Biomarkers & Specialists | Healos | Healos